Nobel Impact

Right to left (standing): Arnold Thackray, president of the Chemical Heritage Foundation; historian of science Tore Frängsmyer of Uppsala University; Alan MacDiarmid (2000 Nobel laureate in chemistry); Joseph Miller of DuPont; historian of science Everett Mendelsohn of Harvard University; Max Perutz (1962); Dudley Herschbach (1986); Rudolph Marcus (1992); and Harold Kroto (1996). Seated: Jerome Karle (1985) and Roald Hoffman (1981). Alfred Nobel, the reclusive inventor of dynamite, probably

Written byEugene Russo
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Right to left (standing): Arnold Thackray, president of the Chemical Heritage Foundation; historian of science Tore Frängsmyer of Uppsala University; Alan MacDiarmid (2000 Nobel laureate in chemistry); Joseph Miller of DuPont; historian of science Everett Mendelsohn of Harvard University; Max Perutz (1962); Dudley Herschbach (1986); Rudolph Marcus (1992); and Harold Kroto (1996). Seated: Jerome Karle (1985) and Roald Hoffman (1981). Alfred Nobel, the reclusive inventor of dynamite, probably had little idea of the explosive impact his posthumous wishes would have on society. Nobel, who died in 1896, willed most of his considerable wealth--garnered from his groundbreaking 1866 invention--to the founding of several international prizes. The prizes were intended to honor those who confer benefit to mankind by promoting peace or by contributing to the fields of physics, chemistry, or physiology or medicine (the economics award was founded later, in 1968). After some legal wrangling by Nobel's family, the first prizes ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies